$24.30
1.566.86%
Last update: Nov 11, 8:03 AM

The average analyst price target for Tango Therapeutics is $37.50, 52.4% above the current price. Of 14 analysts, 13 rate it Buy and 1 Hold. Targets range from $12 to $69. The latest change came on Nov 10, 2026, when JP Morgan raised its price target on Tango Therapeutics from $46 to $47 and kept an Overweight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months